# XELPROS

NDC: 47335-317
Generic name: latanoprost
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC, TOPICAL
Marketing started: 20180912

FDA application: NDA206185

## Active ingredients

- LATANOPROST: .05 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47335-317"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47335-317
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34ad5cf6-4df0-4104-bddd-4c7631133ded